|
RAB8A expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.75569999996783E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.987500E-04 |
| Normal-vs-Stage2 |
1.234180E-01 |
| Normal-vs-Stage3 |
4.09960000000709E-05 |
| Normal-vs-Stage4 |
2.62489999958149E-07 |
| Stage1-vs-Stage2 |
5.598200E-01 |
| Stage1-vs-Stage3 |
9.613700E-02 |
| Stage1-vs-Stage4 |
2.241800E-03 |
| Stage2-vs-Stage3 |
1.166010E-01 |
| Stage2-vs-Stage4 |
1.007610E-02 |
| Stage3-vs-Stage4 |
1.659410E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.89370000025902E-07 |
| Normal-vs-AfricanAmerican |
4.566400E-01 |
| Normal-vs-Asian |
2.901000E-01 |
| Caucasian-vs-AfricanAmerican |
4.316000E-03 |
| Caucasian-vs-Asian |
8.973600E-01 |
| AfricanAmerican-vs-Asian |
2.368200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.419400E-04 |
| Normal-vs-Female |
9.82179999553523E-08 |
| Male-vs-Female |
1.158330E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.416200E-03 |
| Normal-vs-Age(41-60Yrs) |
1.85100000005267E-06 |
| Normal-vs-Age(61-80Yrs) |
8.09460000000817E-05 |
| Normal-vs-Age(81-100Yrs) |
4.356800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.261000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.863800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.793830E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.497800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.092100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.987370E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.602350E-03 |
| Normal-vs-Grade 2 |
5.014100E-04 |
| Normal-vs-Grade 3 |
1.024000E-04 |
| Normal-vs-Grade 4 |
5.57299999481842E-08 |
| Grade 1-vs-Grade 2 |
2.549400E-01 |
| Grade 1-vs-Grade 3 |
3.014000E-01 |
| Grade 1-vs-Grade 4 |
4.051200E-01 |
| Grade 2-vs-Grade 3 |
6.235200E-01 |
| Grade 2-vs-Grade 4 |
3.755000E-04 |
| Grade 3-vs-Grade 4 |
2.664800E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.88260000000473E-05 |
| Normal-vs-ccB subtype |
4.06550000000561E-05 |
| ccA subtype-vs-ccB subtype |
5.956200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.989030E-04 |
| Normal-vs-N1 |
8.71099969934619E-10 |
| N0-vs-N1 |
3.75009999999953E-05 |
|
|
